Results 1 to 10 of about 487,755 (259)

Major depressive disorder [PDF]

Nature Reviews Disease Primers, 2016
Major depressive disorder (MDD) is a debilitating disease that is characterized by depressed mood, diminished interests, impaired cognitive function and vegetative symptoms, such as disturbed sleep or appetite. MDD occurs about twice as often in women than it does in men and affects one in six adults in their lifetime.
Stefan M. Gold, Stefan M. Gold, Christian Otte, Alan F. Schatzberg, Amit Etkin, David C. Mohr, Brenda W.J.H. Penninx, Maurizio Fava, Carmine M. Pariante   +8 more
openaire   +6 more sources

Treating depressive disorders with the unified protocol: A preliminary randomized evaluation. [PDF]

, 2020
OBJECTIVES: This study aims to examine the efficacy of the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP) for individuals diagnosed with a depressive disorder. METHOD: Participants included 44 adults who met criteria for major
Ametaj, Amantia A., Barlow, David H., Bentley, Kate H., Cardona, Nicole, Farchione, Todd J., Nauphal, Maya, Sauer-Zavala, Shannon, Steele, Stephanie Jarvi, Tirpak, Julianne Wilner, Wang, Mengxing   +9 more
core   +2 more sources

The Kimberley assessment of depression of older Indigenous Australians: prevalence of depressive disorders, risk factors and validation of the KICA-dep scale [PDF]

, 2014
This study aimed to develop a culturally acceptable and valid scale to assess depressive symptoms in older Indigenous Australians, to determine the prevalence of depressive disorders in the older Kimberley community, and to investigate the ...
David Atkinson, Dina LoGiudice, Kate Smith, Leon Flicker, Linda Skeaf, Osvaldo P. Almeida, Roslyn Malay, Stephen Fenner, Zoe Hyde   +8 more
core   +10 more sources

Ethiopathogenesis of Depressive Disorders [PDF]

Clinical Practice & Epidemiology in Mental Health, 2014
Etiology of depressive disorders is still unknown. Several factors are involved in its pathophysiology such as neurotransmitters and neuroendocrine alterations, genetics, life events and their appraisal. Some of these components are strictly linked.
Pasquini, M., Berardelli, I., Biondi, M.
openaire   +4 more sources

Inositol for depressive disorders [PDF]

Cochrane Database of Systematic Reviews, 2002
There are a number of effective interventions for the treatment of depression. It is possible that the efficacy of these treatments will be improved further by the use of adjunctive therapies such as inositol.1. To determine the effectiveness of inositol in the treatment of depression.2.
Taylor, M, Wilder, H, Bhagwagar, Z, Geddes, J   +3 more
openaire   +3 more sources

Depressive Disorders

, 2021
Major Depressive Disorder (MDD) and other disorders on the depressive spectrum are more prevalent among HIV-infected individuals than in the general population. These illnesses have a significant impact on prevention, engagement and adherence to HIV care, prognosis, illness-related disability, and quality of life.
FERRARI S, BLANCH J, LAVASANI S, BEALL SC, GIBSON SJ, MAGARINI FM, ALBONI S   +6 more
openaire   +2 more sources

Major Depressive Disorder [PDF]

Neuron, 2000
In summary, MDD is a highly prevalent major medical whose pathophysiology is still poorly understood. MDD is often recurrent or chronic, and evidence suggests that genetic factors partially influence overall risk of illness but also influence the sensitivity of individuals to the depressogenic effects of environmental adversity.
Maurizio Fava, Kenneth S. Kendler
openaire   +2 more sources

'The risks of playing it safe': a prospective longitudinal study of response to reward in the adolescent offspring of depressed parents [PDF]

, 2013
BACKGROUND Alterations in reward processing may represent an early vulnerability factor for the development of depressive disorder. Depression in adults is associated with reward hyposensitivity and diminished reward seeking may also be a feature of ...
A. Rawal, A. Thapar, F. Rice, Howell, S. Collishaw, Wechsler, Weissman   +6 more
core   +1 more source

Prevalence and correlates of depressive disorders in people with Type 2 diabetes: results from the International Prevalence and Treatment of Diabetes and Depression (INTERPRET‐DD) study, a collaborative study carried out in 14 countries [PDF]

, 2018
Aims To assess the prevalence and management of depressive disorders in people with Type 2 diabetes in different countries. Methods People with diabetes aged 18–65 years and treated in outpatient settings were recruited in 14 countries and underwent
Ahmed, H. U., Alvarez, A., Bahendeka, S., Basangwa, D., Boborov, A. E., Boden, S., Bulgari, V., Burti, L., Chaturvedi, S. K., Cimino, L. C., de Girolamo, G., Gaebel, W., Gondek, T. M., Guinzbourg de Braude, M., Guntupalli, A., Heinze, M. G., Hong, X., Ji, L., Kamala, T., Khan, A., Kiejna, A., Kokoszka, A., Lalic, N. M., Lecic Tosevski, D., Li, M., Lloyd, C. E., Mankovsky, B., Musau, A., Mussig, K., Ndetei, D., Nouwen, A., Rabbani, G., Sartorius, N., Shevchuk, M., Srikanta, S. S., Starostina, E. G., Taj, R., Vukovic, O., Wolwer, W., Xin, Y.   +39 more
core   +2 more sources

Morbidity in Depressive Disorders [PDF]

Psychotherapy and Psychosomatics, 2017
Levels of residual morbidity in mood disorder patients followed up long-term under community conditions of treatment are remarkably high [1] . Both unipolar major depressive disorder (MDD) and bipolar disorder (BD) patients were ill 40–50% of follow-up time; in BD patients, three-quarters of that residual morbidity was depressive [1] .
Baldessarini, Ross J., Forte, Alberto, Selle, Valerio, Sim, Kang, Tondo, Leonardo, Undurraga, Juan, Vázquez, Gustavo H.   +6 more
openaire   +3 more sources